Health Canada — Medical Devices · Canada · 2017-10-27 · Type II
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Archived by the issuing authority — kept for reference
Reported risk: The BC Thrombin Reagent Kit lots 46751 (contains Thrombin Reagent lot 517468) and Kit lot 47184 (contains Thrombin Reagent lot 517469) produce unexpected prolonged thrombin time results for expected normal samples, and may recover above the upper limit of normal which is 21 sec as stated within the IFU (instruction for use) and the BCS/ BCS XP System application sheets.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.